As the right to asylum erodes around the world, Assoc. Dean Jaya Ramji-Nogales describes it as “our moral obligation to other humans who are in need of protection because they are facing harm.” Read More

The FDA’s enforcement discretion is backed by case law, says Dean Rebouche, and overturning that would lead to a “major upending of federal agency authority.” Read More

Dean Rebouche explains why the Comstock Act, an anti-vice law from 1873, has taken center stage in the fight over abortion access. Read More

As Massachusetts stockpiles mifepristone, Dean Rebouche says the state can also reassure physicians that they won’t be punished for prescribing it: “it’s the state that governs… the lawful practice of medicine” within its borders. Read More

A Texas judge’s opinion ordering the FDA to withdraw mifepristone could open the door to judge and forum shopping by parties who want to restrict access to other drugs as well, says Dean Rachel Rebouche. Read More

A judicial battle over access to medication abortion is “emblematic of the fight to come,” says Dean Rachel Rebouche. Read More

Conflicting judicial opinions over the FDA’s approval of mifepristone underscore the escalating chaos over abortion in the months since SCOTUS overturned Roe v. Wade, says Dean Rachel Rebouche. Read More    

Dean Rebouche and co-author Greer Donley walk through the conflicting judicial opinions about FDA approval of mifepristone and discuss next steps for the FDA and the Biden administration. Read More

Dean Rachel Rebouche notes that contrary to SCOTUS’s stated purpose in Dobbs, a Texas opinion about mifepristone “deprives states of being able to regulate abortion the way they want.” Read More

Dean Rebouche explains what “enforcement discretion” is and how the FDA can use it to ensure continued access to mifepristone. Read More